Published in J Gen Virol on October 01, 1997
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44
Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A (2001) 4.93
Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol (1999) 2.65
Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol (1998) 2.54
Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol (1998) 2.42
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14
Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol (2004) 1.88
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol (2011) 1.74
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63
Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer. Nucleic Acids Res (2007) 1.62
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PLoS One (2008) 1.37
Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J Virol (2008) 1.35
Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription. J Virol (2003) 1.27
Imaging and characterizing influenza A virus mRNA transport in living cells. Nucleic Acids Res (2008) 1.26
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol (2010) 1.16
Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol (2010) 1.13
Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol (2008) 1.11
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex. J Virol (2010) 1.03
Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS One (2012) 1.03
Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies. Virology (2009) 1.01
Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA. Nucleic Acids Res (2007) 1.01
Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol (2005) 1.01
The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol (2011) 0.98
Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol (2011) 0.96
NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol (2010) 0.95
Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLoS Pathog (2013) 0.95
The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol (2012) 0.93
The splicing factor proline-glutamine rich (SFPQ/PSF) is involved in influenza virus transcription. PLoS Pathog (2011) 0.90
Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds. PLoS One (2013) 0.89
Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication. J Virol (2010) 0.88
Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol (2016) 0.88
Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol (2012) 0.86
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J Virol (2013) 0.85
Alteration of protein levels during influenza virus H1N1 infection in host cells: a proteomic survey of host and virus reveals differential dynamics. PLoS One (2014) 0.84
Conserved features of the PB2 627 domain impact influenza virus polymerase function and replication. J Virol (2014) 0.84
An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo. J Gen Virol (2012) 0.81
Interaction of influenza virus NS1 protein with growth arrest-specific protein 8. Virol J (2009) 0.81
Structural and functional analysis of NS1 and NS2 proteins of H1N1 subtype. Genomics Proteomics Bioinformatics (2010) 0.79
Avian influenza virus NS1: A small protein with diverse and versatile functions. Virulence (2013) 0.78
Nuclear localized Influenza nucleoprotein N-terminal deletion mutant is deficient in functional vRNP formation. Virol J (2014) 0.76
Chemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus Inhibition. MBio (2016) 0.75
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol (1990) 3.44
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet (2000) 2.93
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res (1986) 2.45
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene (1980) 2.44
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene (1988) 2.03
Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol (1994) 2.03
The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: implications for its involvement in mRNA transport. J Neurosci (1999) 2.03
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J (1999) 2.00
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. Gene (1980) 1.95
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res (1996) 1.89
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses. J Gen Virol (1993) 1.74
A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. Mol Cell Biol (1999) 1.74
The influenza A virus PB2 polymerase subunit is required for the replication of viral RNA. J Virol (1997) 1.71
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype. Gene (1983) 1.64
Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J Virol (1992) 1.61
Nuclear transport of influenza virus polymerase PA protein. Virus Res (1992) 1.59
Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle. EMBO Rep (2001) 1.55
Structural determinants of KvLQT1 control by the KCNE family of proteins. J Biol Chem (2000) 1.54
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus. J Virol (1989) 1.50
Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res (1989) 1.49
pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol (1992) 1.48
The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res (1997) 1.48
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J Virol (1999) 1.47
Lung histopathological findings in fatal pandemic influenza A (H1N1). Med Intensiva (2011) 1.46
Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol (1996) 1.43
Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit. J Virol (1996) 1.38
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res (1999) 1.32
Regulated M1 mRNA splicing in influenza virus-infected cells. J Gen Virol (1991) 1.28
Replication of orthomyxoviruses. Adv Virus Res (1999) 1.27
In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. J Gen Virol (1992) 1.26
The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res (1990) 1.24
Degradation of cellular mRNA during influenza virus infection: its possible role in protein synthesis shutoff. J Gen Virol (1992) 1.19
Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J Gen Virol (1995) 1.18
In vitro synthesis of full-length influenza virus complementary RNA. EMBO J (1985) 1.13
Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis. FEBS Lett (2000) 1.12
Cross-links in African swine fever virus DNA. J Virol (1979) 1.10
Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). Gene (1985) 1.10
Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. J Virol (1996) 1.09
Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res (1995) 1.08
The human intersectin genes and their spliced variants are differentially expressed. Biochim Biophys Acta (2001) 1.06
Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant. J Gen Virol (1993) 1.02
Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland. J Endocrinol Invest (2003) 1.01
Inhibition of African swine fever (ASF virus replication by phosphonoacetic acid. J Gen Virol (1978) 1.00
Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J Virol (2000) 1.00
In vivo reconstitution of active Thogoto virus polymerase: assays for the compatibility with other orthomyxovirus core proteins and template RNAs. Virus Res (1998) 0.99
Evolution of the influenza virus neuraminidase gene during drift of the N2 subtype. Virology (1983) 0.99
Molecular cloning of cDNA from foot-and-mouth disease virus C1-Santa Pau (C-S8). Sequence of protein-VP1-coding segment. Gene (1983) 0.98
A primer vector system that allows temperature dependent gene amplification and expression in mammalian cells: regulation of the influenza virus NS1 gene expression. Nucleic Acids Res (1985) 0.98
Oriented synthesis and cloning of influenza virus nucleoprotein cDNA that leads to its expression in mammalian cells. Virus Res (1985) 0.98
A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene (1995) 0.96
Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. J Cell Sci (1997) 0.95
Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome. Eur J Hum Genet (1999) 0.95
Construction of cell lines that regulate by temperature the amplification and expression of influenza virus non-structural protein genes. EMBO J (1986) 0.92
Regulation of gene amplification and expression in cells that constitutively express a temperature sensitive SV40 T-antigen. Nucleic Acids Res (1985) 0.91
Cleavage of p220 by purified poliovirus 2A(pro) in cell-free systems: effects on translation of capped and uncapped mRNAs. Biochemistry (1997) 0.91
Resistance to foot-and-mouth disease virus mediated by trans-acting cellular products. J Virol (1989) 0.91
Heterogeneity among influenza H3N2 isolates recovered during an outbreak. Brief report. Arch Virol (1985) 0.90
An estimation of the nucleotide substitution rate at defined positions in the influenza virus haemagglutinin gene. J Gen Virol (1994) 0.89
Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. Nucleic Acids Res (2000) 0.89
The Bradyrhizobium japonicum fixBCX operon: identification of fixX and of a 5' mRNA region affecting the level of the fixBCX transcript. Mol Microbiol (1989) 0.85
Plasmid vectors based on Tn10 DNA: gene expression regulated by tetracycline. Plasmid (1984) 0.84
Anomalous roughening of viscous fluid fronts in spontaneous imbibition. Phys Rev Lett (2005) 0.83
Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc Natl Acad Sci U S A (1990) 0.82
Permanent cell lines established from ts-COS cells that regulate by temperature the amplification and expression of cloned genes. Nucleic Acids Res (1987) 0.81
Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2. Genes Brain Behav (2009) 0.80